121 related articles for article (PubMed ID: 35385727)
21. Modeling BCR-ABL and MLL-AF9 leukemia in a human bone marrow-like scaffold-based xenograft model.
Sontakke P; Carretta M; Jaques J; Brouwers-Vos AZ; Lubbers-Aalders L; Yuan H; de Bruijn JD; Martens AC; Vellenga E; Groen RW; Schuringa JJ
Leukemia; 2016 Oct; 30(10):2064-2073. PubMed ID: 27125308
[TBL] [Abstract][Full Text] [Related]
22. The CCL2/CCR2 Axis Affects Transmigration and Proliferation but Not Resistance to Chemotherapy of Acute Myeloid Leukemia Cells.
Macanas-Pirard P; Quezada T; Navarrete L; Broekhuizen R; Leisewitz A; Nervi B; Ramírez PA
PLoS One; 2017; 12(1):e0168888. PubMed ID: 28045930
[TBL] [Abstract][Full Text] [Related]
23. Autophagy is dispensable for Kmt2a/Mll-Mllt3/Af9 AML maintenance and anti-leukemic effect of chloroquine.
Chen X; Clark J; Wunderlich M; Fan C; Davis A; Chen S; Guan JL; Mulloy JC; Kumar A; Zheng Y
Autophagy; 2017 May; 13(5):955-966. PubMed ID: 28282266
[TBL] [Abstract][Full Text] [Related]
24. NCAM1 (CD56) promotes leukemogenesis and confers drug resistance in AML.
Sasca D; Szybinski J; Schüler A; Shah V; Heidelberger J; Haehnel PS; Dolnik A; Kriege O; Fehr EM; Gebhardt WH; Reid G; Scholl C; Theobald M; Bullinger L; Beli P; Kindler T
Blood; 2019 May; 133(21):2305-2319. PubMed ID: 30814062
[TBL] [Abstract][Full Text] [Related]
25. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region.
Ishikawa F; Yoshida S; Saito Y; Hijikata A; Kitamura H; Tanaka S; Nakamura R; Tanaka T; Tomiyama H; Saito N; Fukata M; Miyamoto T; Lyons B; Ohshima K; Uchida N; Taniguchi S; Ohara O; Akashi K; Harada M; Shultz LD
Nat Biotechnol; 2007 Nov; 25(11):1315-21. PubMed ID: 17952057
[TBL] [Abstract][Full Text] [Related]
26. c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia.
Xia B; Tian C; Guo S; Zhang L; Zhao D; Qu F; Zhao W; Wang Y; Wu X; Da W; Wei S; Zhang Y
Leuk Res; 2015 Jan; 39(1):92-9. PubMed ID: 25443862
[TBL] [Abstract][Full Text] [Related]
27.
Liu J; Guo B; Chen Z; Wang N; Iacovino M; Cheng J; Roden C; Pan W; Khan S; Chen S; Kyba M; Fan R; Guo S; Lu J
Blood; 2017 Mar; 129(11):1491-1502. PubMed ID: 28053194
[TBL] [Abstract][Full Text] [Related]
28. Acute myeloid leukemia in the vascular niche.
Cogle CR; Bosse RC; Brewer T; Migdady Y; Shirzad R; Kampen KR; Saki N
Cancer Lett; 2016 Oct; 380(2):552-560. PubMed ID: 25963886
[TBL] [Abstract][Full Text] [Related]
29. Oligonucleotide aptamer-drug conjugates for targeted therapy of acute myeloid leukemia.
Zhao N; Pei SN; Qi J; Zeng Z; Iyer SP; Lin P; Tung CH; Zu Y
Biomaterials; 2015 Oct; 67():42-51. PubMed ID: 26204224
[TBL] [Abstract][Full Text] [Related]
30. Acute myeloid leukemia cells require 6-phosphogluconate dehydrogenase for cell growth and NADPH-dependent metabolic reprogramming.
Bhanot H; Weisberg EL; Reddy MM; Nonami A; Neuberg D; Stone RM; Podar K; Salgia R; Griffin JD; Sattler M
Oncotarget; 2017 Sep; 8(40):67639-67650. PubMed ID: 28978059
[TBL] [Abstract][Full Text] [Related]
31. MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment.
Stubbs MC; Kim YM; Krivtsov AV; Wright RD; Feng Z; Agarwal J; Kung AL; Armstrong SA
Leukemia; 2008 Jan; 22(1):66-77. PubMed ID: 17851551
[TBL] [Abstract][Full Text] [Related]
32. Identification of T-lymphocytic leukemia-initiating stem cells residing in a small subset of patients with acute myeloid leukemic disease.
Risueño RM; Campbell CJ; Dingwall S; Levadoux-Martin M; Leber B; Xenocostas A; Bhatia M
Blood; 2011 Jun; 117(26):7112-20. PubMed ID: 21562049
[TBL] [Abstract][Full Text] [Related]
33. Deficient proliferation and expansion in vitro of two bone marrow cell populations from patients with acute myeloid leukemia in response to hematopoietic cytokines.
Montesinos JJ; Sánchez-Valle E; Flores-Figueroa E; Martínez-Jaramillo G; Flores-Guzmán P; Miranda-Peralta E; Gutiérrez-Romero M; Mayani H
Leuk Lymphoma; 2006 Jul; 47(7):1379-86. PubMed ID: 16923572
[TBL] [Abstract][Full Text] [Related]
34. Role of the bone marrow vascular niche in chemotherapy for MLL-AF9-induced acute myeloid leukemia.
Xu C; Lu T; Lv X; Cheng T; Cheng H
Blood Sci; 2023 Apr; 5(2):92-100. PubMed ID: 37228781
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia.
Zhou J; Bi C; Ching YQ; Chooi JY; Lu X; Quah JY; Toh SH; Chan ZL; Tan TZ; Chong PS; Chng WJ
J Hematol Oncol; 2017 Jul; 10(1):138. PubMed ID: 28693523
[TBL] [Abstract][Full Text] [Related]
36. Functional Niche Competition Between Normal Hematopoietic Stem and Progenitor Cells and Myeloid Leukemia Cells.
Glait-Santar C; Desmond R; Feng X; Bat T; Chen J; Heuston E; Mizukawa B; Mulloy JC; Bodine DM; Larochelle A; Dunbar CE
Stem Cells; 2015 Dec; 33(12):3635-42. PubMed ID: 26388434
[TBL] [Abstract][Full Text] [Related]
37. Differential niche and Wnt requirements during acute myeloid leukemia progression.
Lane SW; Wang YJ; Lo Celso C; Ragu C; Bullinger L; Sykes SM; Ferraro F; Shterental S; Lin CP; Gilliland DG; Scadden DT; Armstrong SA; Williams DA
Blood; 2011 Sep; 118(10):2849-56. PubMed ID: 21765021
[TBL] [Abstract][Full Text] [Related]
38. Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice.
Anstee NS; Bilardi RA; Ng AP; Xu Z; Robati M; Vandenberg CJ; Cory S
Cell Death Differ; 2019 Jul; 26(7):1316-1331. PubMed ID: 30470795
[TBL] [Abstract][Full Text] [Related]
39. Maintenance of cellular respiration indicates drug resistance in acute myeloid leukemia.
Henkenius K; Greene BH; Barckhausen C; Hartmann R; Märken M; Kaiser T; Rehberger M; Metzelder SK; Parak WJ; Neubauer A; Brendel C; Mack E
Leuk Res; 2017 Nov; 62():56-63. PubMed ID: 28985623
[TBL] [Abstract][Full Text] [Related]
40. Targeting MTHFD2 in acute myeloid leukemia.
Pikman Y; Puissant A; Alexe G; Furman A; Chen LM; Frumm SM; Ross L; Fenouille N; Bassil CF; Lewis CA; Ramos A; Gould J; Stone RM; DeAngelo DJ; Galinsky I; Clish CB; Kung AL; Hemann MT; Vander Heiden MG; Banerji V; Stegmaier K
J Exp Med; 2016 Jun; 213(7):1285-306. PubMed ID: 27325891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]